Bartholdy N J, Haase J
Radiologisk afdeling, afsnit for interventionel radiologi og neurokirurgisk afdeling, Aalborg Sygehus.
Ugeskr Laeger. 1994 Oct 31;156(44):6541-8.
During two periods (1.1.1981-3.1.1985 and 1.1.1988-31.12.1992) 57 patients were treated or attempted treated with endovascular embolization. The patients suffered either from arteriovenous malformations (AVM), dural arteriovenous malformations (DAVM), carotico-cavernous fistulas (CCF), giant aneurysms or meningenomas. During the first period the balloon-technique was mainly employed and only one isobutyl-2-cyanoacrylate (IBCA) embolization was carried out. Six AVMs and 11 CCFs were treated, and the complication rate was 33%. During the second period histoacryl/N-butyl-cyanoacrylate (NBCA) embolization was the treatment of choice for AVM and DAVM, and the balloon technique reserved for CCF and test occlusions. The complication rate was 8%. In 83% of the AVMs occlusion of more than 50% of the nidus was achieved. Three of five CCFs were occluded with one occluded internal carotid artery. There were no complications in test occlusions. Two DAVMs were reduced in size and the symptoms reduced. The patient material during this period consisted of 19 AVMs, two DAVMs, five CCFs, nine giant aneurysms (test occlusion) and five basal meningenomas with involvement of the internal carotid artery (test occlusion). The treatment of these relatively rare patients consists of close cooperation between the interventional neuroradiologist and the neurosurgical team.
在两个时间段（1981年1月1日至1985年1月3日以及1988年1月1日至1992年12月31日），57例患者接受了或尝试接受了血管内栓塞治疗。这些患者患有动静脉畸形（AVM）、硬脑膜动静脉畸形（DAVM）、颈内动脉海绵窦瘘（CCF）、巨大动脉瘤或脑膜瘤。在第一个时间段，主要采用球囊技术，仅进行了1次异丁基-2-氰基丙烯酸酯（IBCA）栓塞。治疗了6例AVM和11例CCF，并发症发生率为33%。在第二个时间段，组织黏合剂/N-丁基-氰基丙烯酸酯（NBCA）栓塞是AVM和DAVM的首选治疗方法，球囊技术则保留用于CCF和试验性闭塞。并发症发生率为8%。在83%的AVM中，实现了超过50%的畸形团闭塞。5例CCF中有3例闭塞，1例颈内动脉闭塞。试验性闭塞无并发症发生。2例DAVM体积缩小，症状减轻。该时间段的患者包括19例AVM、2例DAVM、5例CCF、9例巨大动脉瘤（试验性闭塞）和5例累及颈内动脉的基底脑膜瘤（试验性闭塞）。对这些相对罕见患者的治疗需要介入神经放射科医生和神经外科团队密切合作。
